The medical device maker flags a drop in stand-alone procedures for its Watchman heart implant, hitting its near-term growth ...

Boston Scientific Corp (NYSE:BSX) dropped 10% Wednesday after Chief Executive Mike Mahoney indicated that standalone Watchman heart implant procedures continue to decline and highlighted near-term ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Boston Scientific remains in focus as healthcare technology trends, structural heart therapies, and competitive developments ...

Valued at a market cap of $71.8 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets minimally ...

Oct 25 (Reuters) - Boston Scientific's BSX.N quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could ...

Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to buy right now. On May 19, TD Cowen ...

A rebounding volume of medical procedures fueled a strong first quarter for Boston Scientific Corp., which topped market expectations for both sales and profits. The company, with significant ...

By Kamal Choudhury May 27 (Reuters) - Boston Scientific shares sank to their lowest in over two years on Wednesday, after the medical device maker warned it was facing pressure due to softer uptake of ...

Oct 25 (Reuters) - Boston Scientific's (BSX.N), opens new tab quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical ...